Global Plant-Derived Chitosan Market Strategic Research Report

Scope of the Report

The global Plant-Derived Chitosan market size is predicted to grow from US$ 227 million in 2025 to US$ 346 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Plant-derived chitosan typically refers to non-animal-derived chitosan—distinguished from that sourced from crustaceans such as shrimp and crabs—and is frequently marketed as plant-based, vegetarian, or non-crustacean chitosan. Strictly speaking, higher plants themselves are not the primary natural source of chitosan; rather, most commercial products are derived from the chitin found within the cell walls of fungi—such as mushrooms, *Aspergillus*, and *Mucor*—which is subsequently converted into chitosan through a deacetylation process. Consequently, the more technically accurate terminology would be "fungal-derived chitosan" or "non-animal-derived chitosan." This class of materials is characterized by its biodegradability, biocompatibility, low allergenicity, and suitability for vegetarian, Halal, and Kosher dietary standards. It finds applications across various sectors, including food preservation, dietary supplements, cosmetics, pharmaceutical excipients, agricultural biostimulants, wound dressings, and eco-friendly adsorbent materials.

The upstream segment of the plant-derived chitosan industry chain primarily encompasses raw materials for fungal fermentation—such as mushrooms, fungal mycelia, Aspergillus, and Mucor—as well as glucose, corn steep liquor, nitrogen sources, acid-base reagents, deacetylation aids, and extraction equipment. The midstream segment involves the cultivation of fungal biomass (or the collection of mushroom by-products), chitin extraction, deacetylation, decolorization and deproteinization, purification, drying, pulverization, and grading; this process yields non-animal-derived chitosan products varying in molecular weight, degree of deacetylation, viscosity, and purity. The downstream segment focuses on applications in food preservation, dietary supplements, cosmetics, agricultural biostimulants, pharmaceutical excipients, wound dressings, water treatment, and environmental adsorption. Compared to traditional chitosan derived from shrimp and crab shells, plant-derived (or fungal-derived) chitosan offers distinct advantages—namely, its non-animal origin, low allergenicity, batch-to-batch consistency, sustainability, and suitability for vegetarian and Halal diets—though it entails higher costs regarding raw materials and fermentation processes. The gross profit margin for plant-derived chitosan stands at approximately 43%.

In 2025, the average price of plant-derived chitosan is projected to reach $80,000 per ton, with a sales volume of 2,900 tons and a total production capacity of 4,142 tons.

More precisely termed fungal-derived (or non-animal-derived) chitosan, plant-derived chitosan represents a premium alternative to traditional chitosan sourced from shrimp and crab shells. Driven by increasing demand across the food, nutraceutical, cosmetic, agricultural, and pharmaceutical sectors for ingredients that are vegetarian-friendly, low-allergen, traceable, sustainable, and "clean label," plant-derived chitosan possesses distinct competitive advantages. It is particularly well-suited for applications such as vegetarian capsules, functional foods, film-forming and antimicrobial agents in cosmetics, agricultural biostimulants, and medical materials. However, the product faces limitations stemming from the high cost of fermentation or fungal raw materials, limited production capacity at scale, a higher price point compared to traditional chitosan, and the fact that downstream market awareness remains in its nascent stages; consequently, it is unlikely to fully displace marine-derived chitosan in the short term. Overall, while the market for plant-derived chitosan remains relatively small in scale, it is characterized by rapid growth, high unit prices, and robust gross margins, positioning it as a pivotal sub-segment driving the chitosan industry's evolution toward non-animal-derived, high-purity, and functionally enhanced products.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Plant-Derived Chitosan market?

What factors are driving Plant-Derived Chitosan market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Plant-Derived Chitosan market opportunities vary by end market size?

How does Plant-Derived Chitosan break out by Type, by Application?

This report presents a comprehensive overview of the global Plant-Derived Chitosan market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Low Degree of Deacetylation (70%–80%)
• Medium Degree of Deacetylation (80%–90%)
• High Degree of Deacetylation (90%–95%)
• Ultra-High Degree of Deacetylation (≥95%)

Segment by Grade

• Industrial Grade
• Food Grade
• Cosmetic Grade
• Pharmaceutical Grade

Segment by Particle Size

• Coarse Powder
• Fine Powder
• Ultrafine Powder

Segment by Application

• Food Industry
• Biopharmaceutical Industry
• Agriculture
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Plant-Derived Chitosan market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Food Industry, Biopharmaceutical Industry, Agriculture evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact